Dorityle 1000 Injection contains Doripenem 1000mg, a powerful carbapenem-class antibiotic developed for the management of serious and life-threatening bacterial infections. It is highly effective against a wide range of gram-positive, gram-negative, and anaerobic bacteria, including multidrug-resistant organisms commonly encountered in hospital settings.
This injectable formulation is widely used in the treatment of complicated intra-abdominal infections, hospital-acquired pneumonia, ventilator-associated pneumonia, urinary tract infections, and sepsis. Its strong bactericidal action and stability against beta-lactamase enzymes make it a preferred choice in critical-care and ICU environments.
For hospitals, institutional buyers, and antibiotic distributors, Dorityle 1000 Injection is a high-value critical-care antibiotic, routinely required in tertiary-care hospitals, ICUs, and infectious-disease departments. Rising antimicrobial resistance ensures consistent demand and repeat institutional procurement.
Adding Dorityle 1000 Injection to your product portfolio strengthens your critical-care and anti-infective therapy segment, opening opportunities in hospital tenders, government supplies, export markets, and third-party manufacturing. Its essential role in managing severe infections makes it a strategically important and profitable product for pharmaceutical distributors.